Campden surgery is a ‘Research Ready Accredited Practice’ and member of the Primary Care Research Network. We participate in a variety of research studies that have been approved by the National Institute for Health Research (NIHR). This means we are working to find ways of improving the care we provide and help to inform future developments in health care.

You may be invited to participate, either by a letter through the post or during an appointment at the surgery. All clinical research is thoroughly checked and approved by ethical committees to ensure that it is appropriate and safe to perform. You will always receive clear information about what taking part in a research study would involve. Your participation is entirely voluntary and can be withdrawn at any time. You are under no obligation to participate in any research project and your care will not be affected in any way if you decided not to take part.

Studies we are currently participating in:

COVID – 19 Studies

IMMUNE DEFENCE study: This study will examine the effectiveness and cost effectiveness of commonly available nasal sprays and a brief physical activity and stress management intervention in preventing and reducing the incidence and severity and duration of respiratory tract infections among patients who may be at risk of serious infection during the COVID pandemic.

Serology (blood sample) study:  You may be offered the opportunity to provide an extra sample at your pre scheduled blood test. This is sample is being used by Public Health England (PHE) to look at the background immunity of the population to COVID-19. You will not receive any results from this blood test.

Other Studies

ACTIVE BRAINS: This study compares a new website designed to help older adults look after their brain and body health with the aim of preventing cognitive decline. The website will help older adults make simple changes such as getting more active, playing brain training games and finding ways to eat more healthily.

SAFER: The aim of this trial is to determine if screening for Atrial Fibrillation in people aged 70 and over leads to reduced incidence of stroke compared to usual care and what impact it has on outcomes.